Telsey Advisory Group Reiterates “Outperform” Rating for Bath & Body Works (NYSE:BBWI)

Bath & Body Works (NYSE:BBWI)‘s stock had its “outperform” rating reaffirmed by equities research analysts at Telsey Advisory Group in a report issued on Thursday, Benzinga reports. They presently have a $42.00 price target on the stock. Telsey Advisory Group’s price target indicates a potential upside of 29.67% from the company’s current price.

Several other equities analysts have also recently issued reports on the company. Piper Sandler lowered their price objective on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating on the stock in a research report on Thursday, July 11th. Citigroup lowered their price target on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating on the stock in a report on Tuesday, August 20th. Evercore ISI decreased their target price on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a report on Wednesday, August 28th. Wells Fargo & Company decreased their target price on Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 24th. Finally, Robert W. Baird cut their price target on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Eight analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Bath & Body Works presently has an average rating of “Moderate Buy” and a consensus price target of $42.35.

Bath & Body Works Stock Up 2.0 %

Shares of BBWI stock opened at $32.39 on Thursday. The business has a 50-day moving average price of $31.85 and a two-hundred day moving average price of $40.31. Bath & Body Works has a 12-month low of $26.20 and a 12-month high of $52.99. The firm has a market cap of $7.10 billion, a P/E ratio of 8.35, a price-to-earnings-growth ratio of 0.96 and a beta of 1.77.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. As a group, research analysts expect that Bath & Body Works will post 3.18 EPS for the current fiscal year.

Institutional Trading of Bath & Body Works

Hedge funds and other institutional investors have recently made changes to their positions in the company. Envestnet Portfolio Solutions Inc. increased its holdings in Bath & Body Works by 5.2% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 5,571 shares of the company’s stock valued at $279,000 after purchasing an additional 277 shares during the last quarter. Empirical Finance LLC lifted its position in Bath & Body Works by 3.6% in the first quarter. Empirical Finance LLC now owns 8,097 shares of the company’s stock valued at $405,000 after acquiring an additional 278 shares during the last quarter. CWM LLC increased its stake in Bath & Body Works by 6.6% in the second quarter. CWM LLC now owns 5,072 shares of the company’s stock valued at $198,000 after purchasing an additional 314 shares during the period. Northwest Bank & Trust Co increased its stake in Bath & Body Works by 2.5% in the first quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock valued at $655,000 after purchasing an additional 315 shares during the period. Finally, DekaBank Deutsche Girozentrale increased its stake in shares of Bath & Body Works by 1.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock worth $1,560,000 after acquiring an additional 322 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.